Nottage Michelle K, Kopciuk Karen A, Tzontcheva Anjela, Andrulis Irene L, Bull Shelley B, Blackstein Martin E
Royal Brisbane Hospital, Herston Road, Herston, Queensland 4029, Australia.
Breast Cancer Res. 2006;8(4):R44. doi: 10.1186/bcr1531.
This study had three aims: to establish the incidence of ipsilateral breast tumour recurrence (IBTR) in a community treatment setting, to evaluate known factors--in particular younger age (< 40 years)--predictive for local recurrence, and to assess the impact of local recurrence on disease-specific survival (DSS).
A consecutive series of 1,540 women with node-negative breast cancer, diagnosed between the ages of 18-75 years, were prospectively accrued between September 1987 and September 1999. All had undergone a resection of the primary breast cancer with clear margins, an axillary lymph node dissection with a minimum of four sampled nodes, and breast-conserving surgery (of any type).
During the study follow-up period, 98 (6.4%) IBTRs and 117 (7.6%) deaths from or with breast cancer were observed. The median time to IBTR was 3.1 years and to death from or with disease was 4.3 years. In the multivariate Cox proportional hazards (PH) regression model for IBTR with adjuvant therapy factors, independent risk factors included age < 40 years (relative risk (RR) = 1.89, 95% confidence interval (CI) of 1.00 - 3.58), presence of intraductal disease (RR = 1.81, 95% CI = 1.15-2.85) and histological grade ('G2' or G3 versus G1: RR = 1.59, 95% CI = 0.87-2.94). In the multivariate Cox PH regression model for DSS with adjuvant therapy factors, independent risk factors included previous IBTR (RR = 2.58, 95% CI = 1.41-4.72), tumor size (1-2 cm versus < 1 cm: RR = 1.95, 95% CI = 1.05-3.64, > 2 cm versus < 1 cm: RR = 2.94, 95% CI = 1.56-5.56), progesterone receptor status (negative or equivocal versus positive or unknown: RR = 2.15, 95% CI = 1.36-3.39), lymphatic invasion (RR = 1.78, 95% CI = 1.17-2.72), and histological grade ('G2' or G3 versus G1: RR = 8.59, 95% CI = 2.09-35.36). The effects of competing risks could be ignored.
The Cox PH analyses confirmed the importance of known risk factors for IBTR and DSS in a community treatment setting. This study also revealed that the early occurrence of an IBTR is associated with a relatively poor five-year survival rate.
本研究有三个目的:确定社区治疗环境中同侧乳腺肿瘤复发(IBTR)的发生率,评估已知因素——特别是年龄较小(<40岁)——对局部复发的预测作用,以及评估局部复发对疾病特异性生存(DSS)的影响。
1987年9月至1999年9月前瞻性纳入了连续的1540例年龄在18 - 75岁之间、淋巴结阴性的乳腺癌女性患者。所有患者均接受了切缘阴性的原发性乳腺癌切除术、至少取样四个淋巴结的腋窝淋巴结清扫术以及保乳手术(任何类型)。
在研究随访期间,观察到98例(6.4%)IBTR和117例(7.6%)因乳腺癌死亡或伴有乳腺癌死亡。至IBTR的中位时间为3.1年,至疾病死亡的中位时间为4.3年。在包含辅助治疗因素的IBTR多变量Cox比例风险(PH)回归模型中,独立危险因素包括年龄<40岁(相对风险(RR)=1.89,95%置信区间(CI)为1.00 - 3.58)、导管内疾病的存在(RR = 1.81,95% CI = 1.15 - 2.85)以及组织学分级(“G2”或G3与G1相比:RR = 1.59,95% CI = 0.87 - 2.94)。在包含辅助治疗因素的DSS多变量Cox PH回归模型中,独立危险因素包括既往IBTR(RR = 2.58,95% CI = 1.41 - 4.72)、肿瘤大小(1 - 2 cm与<1 cm相比:RR = 1.95,95% CI = 1.05 - 3.64,>2 cm与<1 cm相比:RR = 2.94,95% CI = 1.56 - 5.56)、孕激素受体状态(阴性或不确定与阳性或未知相比:RR = 2.15,95% CI = 1.36 - 3.39)、淋巴管浸润(RR = 1.78,95% CI = 1.17 - 2.72)以及组织学分级(“G2”或G3与G1相比:RR = 8.59,95% CI = 2.09 - 35.36)。竞争风险的影响可忽略不计。
Cox PH分析证实了在社区治疗环境中已知风险因素对IBTR和DSS的重要性。本研究还表明,IBTR的早期发生与相对较差的五年生存率相关。